# Legal and Ethics Compliance Summary

Based on an investigation of the repository's legal and architectural documentation (including the DPIA, DPO appointment documents, and the viability report), here is a summary of the platform's stance on US and EU compliance, its classification as a medical tool, and Data Protection Officer (DPO) requirements.

## 1. Do we stand with US and EU compliance?

**EU Compliance (GDPR):**
The platform is designed with a strong "Privacy by Design" approach to meet strict GDPR requirements, specifically concerning the processing of "special categories of data" (Article 9 - Genetic Data).
*   **Architecture:** It employs a Zero-Knowledge / Client-Side processing model. Raw DNA files are parsed and analyzed entirely within the user's browser (via Web Workers) and are never transmitted to the backend.
*   **Storage:** Any saved results are encrypted client-side (AES-256-GCM) using a key derived from the user's password (Argon2id). The server only stores opaque blobs, meaning the company cannot decrypt user health data.
*   **Data Minimization:** By processing ephemerally in RAM and only storing encrypted summaries if explicitly requested, the platform minimizes data exposure.
*   **Sub-processors:** Agreements (SCCs or DPAs) are noted for Tier-1 vendors like Stripe, Resend, Vercel, and Railway.

**US Compliance (FDA & HIPAA):**
*   **HIPAA:** While the platform may not strictly qualify as a "Covered Entity" (as it doesn't integrate directly with healthcare providers), it adopts HIPAA standards (encryption, strict access controls) as a market necessity to build consumer trust.
*   **FDA:** The platform is strategically positioned to avoid FDA regulation as a Class II Medical Device by falling under the "General Wellness" exemption. It focuses on trait prediction and educational insights rather than diagnostic utility.

## 2. What should be done to maintain/achieve compliance?

To fully realize and maintain this compliance posture, the following actions must be taken prior to General Availability (GA) launch:

*   **Appoint an EU Representative:** Since the company targets EU citizens but is based outside the EU, an Article 27 representative must be appointed.
*   **Implement Explicit Consent:** Ensure users affirmatively agree to a dedicated consent modal explaining the processing of special category (genetic) data before any client-side analysis begins (Article 9(2)(a)).
*   **Enforce Disclaimers:** UI must heavily feature disclaimers such as "For Educational, Informational, and Research Purposes Only. Not for Medical Use."
*   **Pass-Through Reporting:** Avoid making independent medical claims. Instead, display the genotype and link out to trusted third-party databases (like ClinVar or SNPedia) for interpretation.
*   **Finalize Documentation:** The Data Protection Impact Assessment (DPIA) and Record of Processing Activities (ROPA) must be formally signed off by the CTO, Legal Counsel, and the appointed DPO.

## 3. Is this a medical tool?

**No. The platform is strictly NOT a medical device.**

*   **Legal Stance:** The Terms of Service and UI explicitly prohibit its use for clinical diagnosis. It is marketed as a "General Wellness" and "Educational" tool.
*   **Technical Reality:** The viability report highlights that Direct-to-Consumer (DTC) genotyping arrays (like those from 23andMe or Ancestry) interrogate less than 0.02% of the human genome. They lack the specific probes required to reliably detect the majority of pathogenic variants for severe recessive disorders. Claiming clinical or diagnostic utility based on this recreational-grade data would be technically flawed and present massive liability risks.

## 4. Is a DPO required?

**Yes. The appointment of a Data Protection Officer (DPO) is legally mandatory.**

*   **Requirement:** Under GDPR Article 37(1)(c), a DPO is required because the platform's core activities involve the "processing on a large scale of special categories of data" (genetic data).
*   **Implementation:** The DPO can be an internal staff member (provided they have no conflict of interest, e.g., they cannot be the CEO or CTO determining how data is processed) or an outsourced "DPO-as-a-Service" provider.
*   **Next Steps:** The DPO must be formally appointed, given necessary resources, and registered with the relevant Data Protection Authority (Supervisory Authority) in the EU.
